in patients with a history of congestive heart failure before randomization , 51 of 345 ( 14.8 % ) in the propranolol group and 46 of 365 ( 12.6 % ) in the placebo group developed congestive heart failure during an average 25 month follow-up .
C0033497
propranolol
C0018802
congestive heart failure